Their use for Alcohol Use Disorder (AUD) or drug addiction is considered "off-label." However, groundbreaking clinical research from 2025 and 2026 demonstrates that these medications significantly dampen the brain's reward centers, drastically curbing cravings for alcohol, opioids, and nicotine
The approval builds on Uzedys 2023 indication for schizophrenia and data from Phase 3 RISE and SHINE trials confirming efficacy and tolerability
While science clearly showed that weight management requires medical expertise and comprehensive support, the existing healthcare system wasnt meeting this need
All studies we identified report that carbon sequestration greatly offsets greenhouse gas emissions from cows, but not necessarily enough to make production carbon-negative (1, 2, 3)
My name is Kyle Richardson, and Im a 34-year-old electrician from Calgary, Alberta